Founders Longevity Forum reveals 2025 London agenda

Founders Longevity Forum reveals 2025 London agenda

In This Article

Article Contents

Agenda explores diagnostics, age reversal and preventative therapeutics as global leaders in science, tech and investment this June.

Co-hosted by Founders Forum Group and Longevity.Technology, the Founders Longevity Forum is set to reconvene in London on 10 June 2025 at OXO2, a central, riverside venue. This event, strategically aligned with London Tech Week, aims to delve into pivotal aspects of the burgeoning longevity sector, encompassing areas such as consumer diagnostics, preventative therapeutics and targeted disease reversal.

The forum’s agenda has been meticulously structured to address several critical themes within the longevity domain. Discussions will encompass consumer diagnostics, focusing on commercial and investment opportunities for both clinical and lifestyle interventions aimed at enhancing healthspan. Among these, the convergence of AI and epigenetics will be a key area of exploration, showcasing how advanced machine learning models are being integrated with DNA methylation and biomarker data to predict aging trajectories and personalize care at scale.

In parallel, the event will also highlight the promise of population-scale health technologies that are pushing digital longevity into the mainstream. Innovations in health data aggregation, continuous monitoring and personalized intervention platforms are enabling society-wide applications of precision health and disease prevention.

The concept of longevity biohacking will be explored through a showcase of commercial and consumer-facing solutions designed to improve metabolism, optimize cellular performance and track biological age in real-time. This session will provide insights into how these tools are being integrated into wellness routines and medical guidance.

Additionally, the forum will examine the rise of longevity clinics, with discussions comparing the evolving roles of both physical, location-based centres and AI-enabled digital clinical networks. Presentations will explore how these clinics deliver professional diagnostics, lifestyle coaching and therapeutic protocols that slow biological aging and extend healthspan – often through hybrid models combining in-person assessments with remote, data-driven care.

Preventative strategies targeting aging-related diseases will also be a focal point, highlighting future clinical interventions that aim to control aging drivers before such diseases manifest. These sessions will be grounded in scientific explainers delivered by leading researchers, offering attendees foundational context on the biology of aging before diving into high-level panel discussions.

The agenda continues into the realm of targeted age reversal, aiming to understand therapeutic interventions that halt or reverse age-related damage in specific organs or for particular age-related diseases, followed by systemic age reversal – innovative therapies addressing damage across the entire body system, representing the next frontier in regenerative medicine.

An impressive roster of speakers has been confirmed for the event, including Brent Hoberman (Founders Forum Group) and Phil Newman (Longevity.Technology), who will open the event. They will be joined by Laura Deming (Cradle, Longevity Fund), Daniel Ives (Shift Bioscience), Matthew Dawson (TruDiagnostic), Bill Kapp (Fountain Life), Sharon Rosenzweig-Lipson (Life Biosciences), Alina Rui Su (Generation Lab), Will Harborne (LongGame Ventures), Eric Morgen (BioAge) and Greg Bailey (Juvenescence), among others.

This assembly of expert speakers and the comprehensive agenda is testament to the forum’s commitment to fostering collaboration among scientists, entrepreneurs and investors. The event aims to examine the latest research, discuss commercialization strategies and explore opportunities to accelerate innovation within the longevity sector. Given the rapid advancements in science, technology and investment in this field, the Founders Longevity Forum offers a timely platform for stakeholders to engage with the evolving landscape of longevity and healthspan extension.

Attendance at the forum is strictly limited to ensure focused discussions and meaningful networking opportunities – prospective participants are encouraged to register their interest promptly to secure a place at this pivotal event. Further details, including additional speaker announcements and agenda updates, will be released in the coming weeks.

The post Founders Longevity Forum reveals 2025 London agenda appeared first on Longevity.Technology – Latest News, Opinions, Analysis and Research.

Key Terms

Longevity technology merges medicine and technology to slow aging, prevent diseases, and extend healthy lifespan through innovation and personalized healthcare.